Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship
Details
Publication Year 2023-07-07,Volume 25,Issue #Suppl 1,Page e14094
Journal Title
Transplant Infectious Disease
Publication Type
Review
Abstract
BACKGROUND: Infectious disease (ID) pharmacists and antimicrobial stewardship (AMS) programs are integral to the infection management of hematopoietic cell transplant (HCT) recipients demonstrating effective implementation of clinical pathways, de-escalation of empirical antibiotics for febrile neutropenia (FN), allergy assessments, and use of rapid diagnostic testing. The HCT procedure is complex, dynamic, and a high risk for infectious complications. Therefore, there is an important role for an ID and AMS pharmacist to collaborate with the primary treating team, with ongoing care, involving the optimal individual patient prophylactic, pre-emptive and treatment management of infections in this high-risk population. CONCLUSION: This review highlights key factors for consideration of ID/AMS Pharmacists in relation to HCT, including important aspects in the evaluation of infection risk prior to transplant, risk from donor sources, length of, and changes in immunosuppression, and potential drug-drug interactions from other essential supportive care therapies.
Publisher
Wiley
Keywords
antimicrobial; hematopoietic cell transplant; infections; pharmacist
Department(s)
Infectious Diseases
PubMed ID
37418600
Open Access at Publisher's Site
https://doi.org/10.1111/tid.14094
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-10-24 04:50:21
Last Modified: 2024-09-05 06:55:59

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙